Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 12Colonic Neoplasms 4Stomach Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Squamous Cell Carcinoma of Head and Neck 1Neuropathy, Painful 1Neuralgia 1Malignant Solid Tumour 1Liver Neoplasms 1Esophageal Neoplasms 1Cold Hypersensitivity 1Carcinoma, Hepatocellular 1CRC 1Advanced Colorectal Cancer 1

Interventions

pembrolizumab 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Folfox protocol 1Fluorouracil 1Bevacizumab 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Malignant Solid Tumour × Folfox protocol × Clear all
NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

SCRI Development Innovations, LLC

Phase 1/2 Completed
49 enrolled 12 charts
GastrointestinalOther solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡